title: Summary of the American Heart Association's scientific statement on drug therapy of high-risk lipid abnormalities in children and adolescents.
authors: Brian W
authors: BW
authors: McCrindle
authors: Elaine M
authors: EM
authors: Urbina
authors: Barbara A
authors: BA
authors: Dennison
authors: Marc S
authors: MS
authors: Jacobson
authors: Julia
authors: J
authors: Steinberger
authors: Albert P
authors: AP
authors: Rocchini
authors: Laura L
authors: LL
authors: Hayman
authors: Stephen R
authors: SR
authors: Daniels
mesh_terms: D000293:Adolescent; D000572:American Heart Association; D002648:Child; D002986:Clinical Trials as Topic / Q000379:methods; D050171:Dyslipidemias / Q000188:drug therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic / Q000592:standards*; D016896:Treatment Outcome
chemical_list: D000960:Hypolipidemic Agents